Ubs Asset Management Americas Inc Abbott Laboratories Transaction History
Ubs Asset Management Americas Inc
- $477 Billion
- Q2 2025
A detailed history of Ubs Asset Management Americas Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 12,749,162 shares of ABT stock, worth $1.67 Billion. This represents 0.36% of its overall portfolio holdings.
Number of Shares
12,749,162
Previous 10,443,759
22.07%
Holding current value
$1.67 Billion
Previous $1.39 Billion
25.17%
% of portfolio
0.36%
Previous 0.37%
Shares
31 transactions
Others Institutions Holding ABT
# of Institutions
3,590Shares Held
1.4BCall Options Held
9.23MPut Options Held
8.1M-
Vanguard Group Inc Valley Forge, PA173MShares$22.6 Billion0.39% of portfolio
-
Black Rock Inc. New York, NY131MShares$17.2 Billion0.31% of portfolio
-
State Street Corp Boston, MA78.4MShares$10.3 Billion0.41% of portfolio
-
Capital International Investors Los Angeles, CA60.1MShares$7.88 Billion1.47% of portfolio
-
Capital Research Global Investors Los Angeles, CA41.8MShares$5.47 Billion1.19% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $229B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...